155 related articles for article (PubMed ID: 33897416)
1. Off-Label Use of Antineoplastic Drugs to Treat Malignancies: Evidence From China Based on a Nationwide Medical Insurance Data Analysis.
Wei G; Wu M; Zhu H; Han S; Chen J; Zhai C; Shi L
Front Pharmacol; 2021; 12():616453. PubMed ID: 33897416
[No Abstract] [Full Text] [Related]
2. The Off-Label Use of Antineoplastics in Oncology Is Limited But Has Notable Scientific Support in a University Hospital Setting.
Herrero Fernandez M; Molina Villaverde R; Arroyo Yustos M; Navarro Expósito F; Lopez Gonzalez JL; Luque Infantes MR; Alvarez-Mon Soto M
Front Pharmacol; 2019; 10():1210. PubMed ID: 31708769
[No Abstract] [Full Text] [Related]
3. Drugs Recommended in Adult Rheumatic Diseases, But Considered for Off-Label Use in Argentina.
Villalobos F; Matellan C; Sequeira G; Kerzberg E
Reumatol Clin (Engl Ed); 2022 May; 18(5):286-292. PubMed ID: 35568442
[TBL] [Abstract][Full Text] [Related]
4. Drugs Recommended in Adult Rheumatic Diseases, But Considered for Off-Label Use in Argentina.
Villalobos F; Matellan C; Sequeira G; Kerzberg E
Reumatol Clin (Engl Ed); 2021 Feb; ():. PubMed ID: 33640322
[TBL] [Abstract][Full Text] [Related]
5. [Comparative assessment of off-label and unlicensed drug prescription in neonatal intensive care: FDA versus Brazilian guidelines].
Costa HTML; Florencio AP; Bezerra PKDV; Cavalcanti JEC; Costa TX; Fernandes FEM; Martins RR
An Pediatr (Engl Ed); 2021 Mar; 94(3):153-160. PubMed ID: 33514478
[TBL] [Abstract][Full Text] [Related]
6. Comparative Assessment of Off-label and Unlicensed Drug Prescriptions in Children: FDA Versus ANSM Guidelines.
Berdkan S; Rabbaa L; Hajj A; Eid B; Jabbour H; Osta NE; Karam L; Khabbaz LR
Clin Ther; 2016 Aug; 38(8):1833-44. PubMed ID: 27392716
[TBL] [Abstract][Full Text] [Related]
7. Off-label use and harmful potential of drugs in a NICU in Brazil: A descriptive study.
de Souza AS; Dos Santos DB; Rey LC; Medeiros MG; Vieira MG; Coelho HLL
BMC Pediatr; 2016 Jan; 16():13. PubMed ID: 26795213
[TBL] [Abstract][Full Text] [Related]
8. Unlicensed/Off-Label Drug Prescriptions at Hospital Discharge in Children: An Observational Study Using Routinely Collected Health Data.
Jaberi E; Boussaha I; Dode X; Grenet G; Kassai B; Nguyen KA
Healthcare (Basel); 2024 Jan; 12(2):. PubMed ID: 38255096
[TBL] [Abstract][Full Text] [Related]
9. Off-label and unlicensed drug use in children population.
Moulis F; Durrieu G; Lapeyre-Mestre M
Therapie; 2018 Apr; 73(2):135-149. PubMed ID: 29580614
[TBL] [Abstract][Full Text] [Related]
10. Off-Label and Off-NCCN Guidelines Uses of Antineoplastic Drugs in China.
Wang W; Zhu M; Guo D; Chen C; Wang D; Pei F; Ma L
Iran J Public Health; 2013; 42(5):472-9. PubMed ID: 23802104
[TBL] [Abstract][Full Text] [Related]
11. [Justification of off-label antibiotics uses in hospitalized children].
Berthod C; Kassaï B; Boussageon R; ; Adelaide L; Jacquet-Lagrèze M; Lajoinie A
Therapie; 2017 Dec; 72(6):649-658. PubMed ID: 28647107
[TBL] [Abstract][Full Text] [Related]
12. Use of off-label and unlicensed drugs in the neonatal intensive care unit and its association with severity scores.
Carvalho CG; Ribeiro MR; Bonilha MM; Fernandes M; Procianoy RS; Silveira RC
J Pediatr (Rio J); 2012; 88(6):465-70. PubMed ID: 23108602
[TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
14. Off-label drug use in pediatric patients: a comparative analysis with nationwide routine prescription data.
Akıcı N; Kırmızı Nİ; Aydın V; Bayar B; Aksoy M; Akıcı A
Turk J Pediatr; 2020; 62(6):949-961. PubMed ID: 33372433
[TBL] [Abstract][Full Text] [Related]
15. National comprehensive cancer network recommendations for drugs without US food and drug administration approval in metastatic breast cancer: A cross-sectional study.
Etan T; Amir E; Tibau A; Yerushalmi R; Moore A; Shepshelovich D; Goldvaser H
Cancer Treat Rev; 2020 Dec; 91():102113. PubMed ID: 33128993
[TBL] [Abstract][Full Text] [Related]
16. Off-label and unlicensed medication use and associated adverse drug events in a pediatric emergency department.
Phan H; Leder M; Fishley M; Moeller M; Nahata M
Pediatr Emerg Care; 2010 Jun; 26(6):424-30. PubMed ID: 20502385
[TBL] [Abstract][Full Text] [Related]
17. Off-label and unlicensed drug use in children admitted to Pediatric Intensive Care Units (PICU).
Jobanputra N; Save SU; Bavdekar SB
Int J Risk Saf Med; 2015; 27(3):113-21. PubMed ID: 26410245
[TBL] [Abstract][Full Text] [Related]
18. Off-label use of antimicrobials in neonates in a tertiary children's hospital.
Laine N; Kaukonen AM; Hoppu K; Airaksinen M; Saxen H
Eur J Clin Pharmacol; 2017 May; 73(5):609-614. PubMed ID: 28101656
[TBL] [Abstract][Full Text] [Related]
19. [Analysis on off-label use of drugs in pediatric guidelines and consensus published by Chinese authors].
Meng M; Wang P; Lan H; Lei WJ; Shen Q; Zhou Q; Su RF; Lyu M; Yang B; Luo XF; Lei RB; Hou TC; Li Q; Chen Y
Zhonghua Er Ke Za Zhi; 2022 Mar; 60(3):215-220. PubMed ID: 35240741
[No Abstract] [Full Text] [Related]
20. Systematic review: reliability of compendia methods for off-label oncology indications.
Abernethy AP; Raman G; Balk EM; Hammond JM; Orlando LA; Wheeler JL; Lau J; McCrory DC
Ann Intern Med; 2009 Mar; 150(5):336-43. PubMed ID: 19221366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
